Rein Therapeutics Inc. (RNTX)
NASDAQ · Healthcare
Rein Therapeutics Inc. Operating Income 2015–2025
Rein Therapeutics Inc. annual/quarterly operating income history and growth rate from 2015 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Rein Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -5.2 M, a 6.76% decrease year-over-year.
- Rein Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -23.2 M, a 4.51% decrease year-over-year.
- Rein Therapeutics Inc. annual operating income for 2025 was -50.6 M, a 22.24% decrease from 2024.
- Rein Therapeutics Inc. annual operating income for 2024 was -65.1 M, a 300.05% increase from 2023.
- Rein Therapeutics Inc. annual operating income for 2023 was -16.3 M, a 41.13% decrease from 2022.
- Rein Therapeutics Inc. annual operating income for 2022 was -27.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rein Therapeutics Inc. Operating Income — FAQ
Rein Therapeutics Inc. (RNTX) operating income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Rein Therapeutics Inc.'s operating income?
Rein Therapeutics Inc. (RNTX) reported operating income of -$51M for fiscal 2025.
Where can I see RNTX's operating income history?
The chart and table above show Rein Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.